The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,232.00
Bid: 2,232.00
Ask: 2,234.00
Change: -26.00 (-1.15%)
Spread: 2.00 (0.09%)
Open: 2,253.00
High: 2,263.00
Low: 2,222.00
Prev. Close: 2,258.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

3 Apr 2008 15:22

Halma PLC03 April 2008 Halma p.l.c. BOARD RETIREMENT AND APPOINTMENT Halma p.l.c., the leading safety, health and sensor technology group, todayannounces the forthcoming retirement of Keith Roy as an Executive Director andthe appointment of Adam Meyers to the Board. Keith Roy, 57, has given notice that he will retire and resign as a Directorwith effect from 31 July 2008. In accordance with Halma's internal successionplanning processes and to ensure a smooth handover, Adam Meyers will beappointed as an Executive Director with immediate effect. Adam Meyers, 46, has been a member of Halma's Executive Board since April 2003as the Divisional Chief Executive responsible for the Fluid Technology Divisionwithin Halma's Health and Analysis sector. Prior to that, he was an AssistantDivisional Chief Executive and President of Bio-Chem Valve, having joined theGroup in 1996. He is a graduate of the University of Pennsylvania and has anMBA from Harvard Business School. Geoff Unwin, Halma's Chairman, commented: "I would like to record my thanks to Keith Roy who has made a tremendouscontribution to the success of Halma since he sold his business to the group in1993. Amongst his many achievements, Keith has been unceasing in his efforts todevelop talent throughout the organisation. The value of this is clearly seenby the increase in internal promotions in recent years, particularly at HalmaExecutive Board level. "We welcome Adam Meyers to the Halma Board. In his 11 years with the group,Adam has built a strong track record of achievement contributing both consistentorganic growth and acquisitions to our success. His knowledge of many of ourHealth and Analysis markets, particularly in the US, will bring an addeddimension to the Board." For further information, please contact: Andrew Williams, Chief Executive +44 (0)1494 721111Halma p.l.c. Rachel Hirst/Andrew Jaques +44 (0)20 7357 9477Hogarth Partnership Limited Notes i) A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com ii) At the date of this announcement Adam Meyers has the following interests in the ordinary shares of Halma: - a beneficial interest in 41,689 shares (of which 4,544 are held via the Halma Holdings Inc. Profit Sharing Savings Retirement Plan (a 401k plan)) - outstanding options in respect of 503,881 shares at a weighted average exercise price per share of 132.64 pence - outstanding Performance Share Plan awards in respect of 226,368 shares vesting from August 2008. Adam Meyers has not held any directorships of publicly quoted companies in thelast five years. There are no further details to disclose under paragraph9.6.13 of the Listing Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.